James Hambro & Partners LLP decreased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 0.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 242,622 shares of the medical equipment provider’s stock after selling 2,187 shares during the period. Intuitive Surgical comprises about 5.0% of James Hambro & Partners LLP’s holdings, making the stock its 7th largest position. James Hambro & Partners LLP owned approximately 0.07% of Intuitive Surgical worth $126,664,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors have also bought and sold shares of the stock. Bennett Selby Investments LP increased its position in shares of Intuitive Surgical by 3.9% during the fourth quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider’s stock valued at $234,000 after acquiring an additional 17 shares during the last quarter. LVW Advisors LLC grew its stake in Intuitive Surgical by 1.3% in the 4th quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider’s stock valued at $756,000 after purchasing an additional 19 shares during the period. Wesbanco Bank Inc. increased its position in shares of Intuitive Surgical by 1.6% during the 4th quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider’s stock valued at $635,000 after purchasing an additional 19 shares during the last quarter. Hazlett Burt & Watson Inc. raised its stake in shares of Intuitive Surgical by 5.8% during the 3rd quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock worth $177,000 after purchasing an additional 20 shares during the period. Finally, Mitchell Mcleod Pugh & Williams Inc. boosted its holdings in shares of Intuitive Surgical by 4.1% in the 3rd quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock worth $247,000 after buying an additional 20 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.
Intuitive Surgical Stock Performance
ISRG stock opened at $584.05 on Monday. The firm has a market cap of $208.03 billion, a P/E ratio of 93.90, a P/E/G ratio of 5.19 and a beta of 1.39. The firm’s fifty day moving average is $547.16 and its 200 day moving average is $505.21. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00.
Wall Street Analysts Forecast Growth
Check Out Our Latest Report on ISRG
Insider Buying and Selling at Intuitive Surgical
In other Intuitive Surgical news, CEO Gary S. Guthart sold 18,151 shares of the firm’s stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the sale, the chief executive officer now owns 24,219 shares of the company’s stock, valued at $12,391,166.97. This trade represents a 42.84 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction dated Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total transaction of $95,225.76. Following the transaction, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,788,899.12. This trade represents a 3.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 42,453 shares of company stock worth $22,059,506 over the last three months. Company insiders own 0.90% of the company’s stock.
Intuitive Surgical Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles
- Five stocks we like better than Intuitive Surgical
- How to Capture the Benefits of Dividend Increases
- The 3 Biggest M&A Stock Opportunities for 2025
- The Most Important Warren Buffett Stock for Investors: His Own
- A Pivotal Moment for the Consumer Discretionary Sector
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- How Mixed Analyst Opinions Are Shaping Apple Stock’s Outlook
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.